4//SEC Filing
Boudreau Helen M 4
Accession 0001209191-23-044635
CIK 0001346830other
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 5:20 PM ET
Size
5.6 KB
Accession
0001209191-23-044635
Insider Transaction Report
Form 4
Boudreau Helen M
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-08-02+155,747→ 155,747 totalExercise: $3.09Exp: 2033-08-02→ Common Stock (155,747 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable in twelve (12) equal quarterly installments beginning on August 2, 2023 such that the option will be fully vested and exercisable on August 2, 2026, subject to the Reporting Person's continued service to the Issuer on each such date.
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeother
Related Parties
1- filerCIK 0001661481
Filing Metadata
- Form type
- 4
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 5:20 PM ET
- Size
- 5.6 KB